What Is (S)-2-hydroxy-acid oxidase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 10, 2026

Quick Answer: (S)-2-hydroxy-acid oxidase is a flavoprotein enzyme that catalyzes the oxidation of L-2-hydroxy acids to corresponding α-keto acids, containing FAD as a prosthetic group and functioning primarily in peroxisomes. First isolated and characterized in the 1970s, this enzyme plays a critical role in amino acid metabolism and the detoxification of D-lactic acid and other hydroxy acids in mammals and microorganisms.

Key Facts

FAD-dependent enzyme classified as an oxidoreductase that catalyzes the conversion of (S)-2-hydroxy acids to α-keto acids with high stereospecificity
Located primarily in peroxisomes of mammalian cells, contributing to amino acid catabolism and metabolic homeostasis
Exhibits broad substrate specificity for L-configured 2-hydroxy acids including lactate, glycerate, and mandelic acid
First comprehensively characterized in the 1970s-1980s with molecular weight ranging from 38-48 kDa depending on source organism
Clinical significance in D-lactic acidosis metabolism and potential biomarker for peroxisomal disorders and metabolic diseases

Overview

(S)-2-hydroxy-acid oxidase is a flavoprotein enzyme that catalyzes the oxidative deamination of L-2-hydroxy acids to their corresponding α-keto acids. This enzyme belongs to the oxidoreductase family (EC 1.1.3.2 classification) and is characterized by its requirement for FAD (flavin adenine dinucleotide) as a prosthetic group, which serves as the electron acceptor in the oxidation reaction. The enzyme demonstrates remarkable stereospecificity for (S)-configured substrates, distinguishing it from non-specific acid oxidases.

Originally isolated from mammalian tissues and later identified in bacteria and fungi, (S)-2-hydroxy-acid oxidase has been extensively studied since the 1970s. It functions as a soluble protein with molecular weights typically ranging from 38 to 48 kilodaltons, depending on the source organism. The enzyme's presence in peroxisomes marks it as a key player in cellular metabolism, participating in amino acid catabolism, fatty acid oxidation pathways, and the metabolism of exogenous compounds. Its discovery revolutionized understanding of how cells handle L-configured hydroxy acids and their role in intermediary metabolism.

How It Works

The catalytic mechanism of (S)-2-hydroxy-acid oxidase involves a sophisticated multi-step process. The enzyme accepts (S)-2-hydroxy acids as substrates, including lactate, glycerate, mandelate, and other L-configured compounds with hydroxyl groups at the α-carbon position.

Substrate Binding: The (S)-2-hydroxy acid substrate binds to the enzyme's active site with high stereochemical selectivity, positioning the hydroxyl group for oxidation while the FAD cofactor is reduced to FADH₂.
Oxidation Reaction: The enzyme catalyzes the removal of two hydrogen atoms from the substrate, converting the secondary hydroxyl group to a ketone group, forming an α-keto acid product while simultaneously reducing FAD.
Electron Transfer: Electrons from the oxidation are transferred through the reduced FAD cofactor to molecular oxygen or other electron acceptors, ultimately generating hydrogen peroxide (H₂O₂) as a byproduct in aerobic conditions.
Product Release: The newly formed α-keto acid is released from the enzyme, and the FAD cofactor is regenerated through interaction with peroxisomal catalase or other flavoprotein oxidoreductases.
Cofactor Recycling: The enzyme's FAD prosthetic group undergoes continuous reduction and oxidation cycles, enabling multiple catalytic turnovers without cofactor dissociation from the protein structure.

Key Comparisons

Feature	(S)-2-Hydroxy-Acid Oxidase	Related Oxidoreductases	Comparison Context
Substrate Specificity	L-configured 2-hydroxy acids (lactate, glycerate)	D-amino acid oxidase (D-configured)	(S)-2-hydroxy-acid oxidase shows strict (S)-stereoselectivity versus D-specific alternatives
Cellular Localization	Peroxisomes (primary), also cytoplasm	Mitochondria (cytochrome oxidase), cytoplasm (lactate dehydrogenase)	Peroxisomal location distinguishes it from glycolytic and respiratory chain enzymes
Cofactor Requirement	FAD (flavin adenine dinucleotide)	NAD⁺/NADH (dehydrogenases), Heme (oxidases)	FAD-dependent mechanism differs from NAD⁺-dependent lactate dehydrogenase
Product Generated	α-keto acid + H₂O₂	Lactate dehydrogenase (pyruvate/lactate), Catalase (H₂O breakdown)	Produces both product and H₂O₂ byproduct unlike anaerobic dehydrogenases
Molecular Weight	38-48 kDa (monomeric)	120-130 kDa (lactate dehydrogenase, tetrameric)	Smaller, simpler quaternary structure than many metabolic enzymes

Why It Matters

Amino Acid Metabolism: (S)-2-hydroxy-acid oxidase catalyzes critical steps in the degradation of amino acids containing hydroxy groups, including threonine, serine, and other proteinogenic amino acids, contributing to nitrogen balance and energy metabolism.
D-Lactic Acidosis Treatment: The enzyme plays a significant role in metabolizing D-lactic acid, a pathological byproduct in short bowel syndrome and bacterial overgrowth. Impaired enzyme activity can lead to dangerous acidosis with neurological complications.
Metabolic Detoxification: Beyond endogenous substrates, (S)-2-hydroxy-acid oxidase metabolizes exogenous hydroxy acids encountered through diet or pharmaceutical administration, protecting cells from accumulation of toxic compounds.
Peroxisomal Function: As a peroxisomal marker enzyme, its activity indicates proper peroxisomal biogenesis and function, making it diagnostically valuable for detecting peroxisomal disorders like Zellweger syndrome and adrenoleukodystrophy.
Metabolic Disorder Biomarker: Elevated or deficient enzyme activity serves as a clinical marker for various metabolic diseases, storage disorders, and mitochondrial dysfunction, guiding diagnosis and treatment strategies.

The clinical importance of (S)-2-hydroxy-acid oxidase extends beyond basic biochemistry into therapeutic applications. Understanding enzyme kinetics has enabled development of targeted interventions for patients with metabolic disorders. Researchers continue investigating enzyme regulation, its role in oxidative stress via H₂O₂ production, and its potential as a pharmaceutical target. The enzyme exemplifies how a seemingly specialized metabolic catalyst connects to broader cellular health, organellar function, and systemic disease management in modern clinical medicine.